ANKRD60

Across TCGA pan-cancer cohorts, ANKRD60 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ANKRD60 data layer compared with 13 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher ANKRD60 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated ANKRD60 expression acts as an unfavorable survival marker.

GBM and HNSC are the cancer types where ANKRD60 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	OS	Quartile	All	0.316	0.682	.037	2	view →
HNSC	OS	Tertile	IV	0.593	0.909	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ANKRD60–GBM (OS)

Open the GBM breakdown →